Re-engagement strategies for hepatitis B show promise in the US, but data gaps and structural barriers are slowing progress ...
A group of independent vaccine advisers to the US Centers for Disease Control and Prevention is meeting this week, and a key item on the agenda is the hepatitis B vaccine. After presentations about ...
Whether declined level <10 mIU/ml of antibody to hepatitis B surface antigen (anti-HBs) is still immune to hepatitis B virus (HBV) is controversial. We longitudinally investigated hepatitis B markers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results